Across TCGA pan-cancer cohorts, EIF2S2P5 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of EIF2S2P5’s most consistent transcriptional readouts.

The strongest signal is observed in stomach adenocarcinoma (STAD), where EIF2S2P5 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types EIF2S2P5 is over-expressed in tumor.

STAD, COAD, and KIRC are the cancer types where EIF2S2P5 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in EIF2S2P5 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
STAD	All	II,III,IV	+0.116	<.001	5	view →
COAD	All	All	+0.040	.032	1	view →
KIRC	All	All	+0.017	.032	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: EIF2S2P5 RNA expression & survival · all EIF2S2P5 data types